Key result
Mutations at arginines in S4 voltage sensors in hypokalaemic periodic paralysis support an alternative pathway for ion conduction, the gating pore, causing aberrant depolarization and weakness.
Hypokalaemic periodic paralysis mutations in S4 voltage sensors create an alternative ion conduction pathway (gating pore) that may explain depolarization-induced weakness.
Answers are grounded in this paper and cite their sources.
Resolves depolarization enigma in channelopathies; leaves open clinical translation to targeted therapies.
Mutations of voltage-gated ion channels cause several channelopathies of skeletal muscle, which present clinically with myotonia, periodic paralysis, or a combination of both. Expression studies have revealed both loss-of-function and gain-of-function defects for the currents passed by mutant channels. In many cases, these functional changes could be mechanistically linked to the defects of fibre excitability underlying myotonia or periodic paralysis. One remaining enigma was the basis for depolarization-induced weakness in hypokalaemic periodic paralysis (HypoPP) arising from mutations in either sodium or calcium channels. Curiously, 14 of 15 HypoPP mutations are at arginines in S4 voltage sensors, and recent observations show that these substitutions support an alternative pathway for ion conduction, the gating pore, that may be the source of the aberrant depolarization during an attack of paralysis.
No takes yet. Share an insight, caveat, or question.
Stephen C. Cannon (2010) conducted a review in Channelopathies of skeletal muscle (myotonia, periodic paralysis). Voltage-sensor mutations (arginines in S4 voltage sensors) was evaluated. Mutations at arginines in S4 voltage sensors in hypokalaemic periodic paralysis support an alternative pathway for ion conduction, the gating pore, causing aberrant depolarization and weakness.
Synapse has enriched 10 related papers. Consider them for comparative context: